Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2000
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex
K Hofland, B O Petersen, J Falck, et al.
Ugeskrift for Laeger
|
April 30, 1984
[Chronic toxic encephalopathy following occupational exposure to organic solvents. The course after cessation of exposure illustrated by a neurophysiological follow-up study]
P B Jensen, P Nielsen, N O Nielsen, et al.
Blood Purification
|
January 1, 1997
Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility
K E Otte, P B Jensen, P Svendsen, et al.
British Journal of Cancer
|
July 4, 1998
Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer
J Kreisholt, M Sorensen, P B Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 14, 1998
Quantification of the N-terminal propeptide of human procollagen type I (PINP): comparison of ELISA and RIA with respect to different molecular forms
C H Jensen, M Hansen, J Brandt, et al.
Biochemical Pharmacology
|
August 3, 1993
Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)
M Sehested, P B Jensen, B S Sørensen, et al.
FEBS Letters
|
October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance
L H Jensen, I Wessel, M Møller, et al.
Histopathology
|
August 2, 2008
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
L Marquard, L M Gjerdrum, Ib J Christensen, et al.
Acta Neurologica Scandinavica
|
March 1, 1981
Sexual and hypothalamic dysfunction in the postconcussional syndrome
M Kosteljanetz, T S Jensen, B Nørgård, et al.
Clinical Nephrology
|
February 8, 2000
Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment
P B Jensen, B Ekelund, F T Nielsen, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2000
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex
K Hofland, B O Petersen, J Falck, et al.
Ugeskrift for Laeger
|
April 30, 1984
[Chronic toxic encephalopathy following occupational exposure to organic solvents. The course after cessation of exposure illustrated by a neurophysiological follow-up study]
P B Jensen, P Nielsen, N O Nielsen, et al.
Blood Purification
|
January 1, 1997
Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility
K E Otte, P B Jensen, P Svendsen, et al.
British Journal of Cancer
|
July 4, 1998
Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer
J Kreisholt, M Sorensen, P B Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 14, 1998
Quantification of the N-terminal propeptide of human procollagen type I (PINP): comparison of ELISA and RIA with respect to different molecular forms
C H Jensen, M Hansen, J Brandt, et al.
Biochemical Pharmacology
|
August 3, 1993
Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)
M Sehested, P B Jensen, B S Sørensen, et al.
FEBS Letters
|
October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance
L H Jensen, I Wessel, M Møller, et al.
Histopathology
|
August 2, 2008
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
L Marquard, L M Gjerdrum, Ib J Christensen, et al.
Acta Neurologica Scandinavica
|
March 1, 1981
Sexual and hypothalamic dysfunction in the postconcussional syndrome
M Kosteljanetz, T S Jensen, B Nørgård, et al.
Clinical Nephrology
|
February 8, 2000
Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment
P B Jensen, B Ekelund, F T Nielsen, et al.
Page
of 12